New treatments for type 2 diabetes in the UK - an evolving landscape.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20934929.
- Also identified by DOI 10.1016/j.pcd.2010.09.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New classes of treatments for type 2 diabetes have been developed recently and are now available in the UK. This review aims to summarise key clinical efficacy, tolerability and safety data for these agents, including liraglutide, which has received preliminary review by the National Institute for Clinical Excellence (NICE) and was launched in the UK in 2009.
Medical subject headings
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents